NSCLC, Stage IB-IIIA
Oncology·MeSH: Carcinoma, Non-Small-Cell Lung
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| tas6417 | CG Oncology, Inc. (CGON) |
Frequently asked questions
How many drugs are in development for NSCLC, Stage IB-IIIA?
BioSniper tracks 1 drug in development for NSCLC, Stage IB-IIIA across 1 company.
How many clinical trials target NSCLC, Stage IB-IIIA?
There are 1 clinical trial targeting NSCLC, Stage IB-IIIA tracked by BioSniper.
Deep-dive into NSCLC, Stage IB-IIIA
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis